Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2026
Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 16, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language Models.
Journal: JCO precision oncology
Published: March 05, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 23, 2026
OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance.
Journal: Molecular cancer research : MCR
Published: August 22, 2025
Lossless Altered Histone Modification Analysis System (LAHMAS).
Journal: Lab on a chip
Published: July 07, 2025
OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Perspectives on digital health and advanced treatment referral in Parkinson's care among Danish neurologists: a mixed methods study.
Journal: Frontiers in neurology
Published: April 25, 2025
Identifying prognostic targets in metastatic prostate cancer beyond AR.
Journal: FEBS open bio
Published: March 24, 2025
Transcriptomic Signatures of Monocyte-Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer.
Journal: The Prostate
Published: February 17, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels.
Journal: Nature communications
Published: December 17, 2024
Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response.
Journal: Communications biology
Published: December 04, 2024
Last Updated: 09/26/2026